Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

MLL1 antibody

This Rabbit Polyclonal antibody specifically detects MLL1 in ChIP, ELISA and ChIP-seq. It exhibits reactivity toward Human.
Catalog No. ABIN6952424

Quick Overview for MLL1 antibody (ABIN6952424)

Target

See all MLL1 Antibodies
MLL1 (Myeloid/lymphoid Or Mixed-Lineage Leukemia 1 (MLL1))

Reactivity

Human

Host

  • 5
Rabbit

Clonality

  • 4
  • 1
Polyclonal

Conjugate

  • 5
This MLL1 antibody is un-conjugated

Application

  • 4
  • 4
  • 1
  • 1
Chromatin Immunoprecipitation (ChIP), ELISA, ChIP DNA-Sequencing (ChIP-seq)

Grade

ChIP-seq Grade
  • Specificity

    Polyclonal antibody raised in rabbit against human MLL1 (Mixed-Lineage Leukemia) using two KLH-conjugated synthetic peptides containing a sequence from the central region of the protein.

    Purification

    whole antiserum

    Immunogen

    synthetic peptide
  • Application Notes

    ChIP/ChIP-seq 2 μL:ChIP
    ELISA 1:100 - 1:1,000

    Restrictions

    For Research Use only
  • Format

    Liquid

    Buffer

    serum, 0.05 % azide

    Preservative

    Sodium azide

    Precaution of Use

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    -20 °C
  • Target

    MLL1 (Myeloid/lymphoid Or Mixed-Lineage Leukemia 1 (MLL1))

    Alternative Name

    MLL1

    Background

    MLL1 (UniProtKB/Swiss-Prot entry Q03164) functions as a lysine methyltransferase responsible for the methylation of H3K4 which is associated with epigenetic transcriptional activation. MLL1 regulates the transcription of specific target genes, including many of the HOX genes and plays an essential role in regulating gene expression during early development and hematopoiesis. It also plays a role in the control of circadian gene expression. Mll1 is involved in several translocations which cause certain acute lymphoid leukemias and acute myeloid leukemias.

    UniProt

    Q03164
You are here:
Chat with us!